home > drugs a-z list > olux-e (clobetasol propionate foam) drug center > olux-e (clobetasol propionate foam) drug - side effects and drug interactions

Recommended Topic Related To:

Olux-E

Psoriasis facts

  • Psoriasis is a chronic inflammatory skin disease.
  • Psoriasis has no known cause.
  • The tendency toward developing psoriasis is inherited in genes.
  • Psoriasis is not contagious.
  • Psoriasis gets better and worse spontaneously and can have periodic remissions (clear skin).
  • Psoriasis is controllable with medication.
  • Psoriasis is currently not curable.
  • There are many promising therapies, including newer biologic drugs.
  • Future research for psoriasis is promising.

What is psoriasis?

Psoriasis is a noncontagious skin condition that produces red, dry plaques of thickened skin. The dry flakes and skin scales are thought to result from the rapid proliferation of skin cells that is triggered by abnormal lymphocytes from the blood . Psoriasis commonly affects the skin of the elbows, knees, and scalp.

Some people have such mild ps...

Olux-E

font size

SIDE EFFECTS

Clinical Trials Experience

In controlled clinical trials involving 821 subjects exposed to Olux-E (clobetasol propionate foam) Foam and Vehicle Foam, the pooled incidence of local adverse reactions in trials for atopic dermatitis and psoriasis with Olux-E (clobetasol propionate foam) Foam was 1.9% for application site atrophy and 1.6% for application site reaction. Most local adverse events were rated as mild to moderate and they were not affected by age, race, or gender. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

The following additional local adverse reactions have been reported with topical corticosteroids: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, irritation, striae, and miliaria. They may occur more frequently with the use of occlusive dressings and higher potency corticosteroids, such as clobetasol propionate.

Cushing's syndrome has been reported in infants and adults as a result of prolonged use of topical clobetasol propionate formulations.

Postmarketing Experience

The following adverse reactions have been identified during post-approval use of clobetasol formulations: erythema, pruritus, burning, alopecia, and dryness.

Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

DRUG INTERACTIONS

No information provided.

Last reviewed on RxList: 12/16/2010
This monograph has been modified to include the generic and brand name in many instances.

Olux-E - User Reviews

Olux-E User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Olux-E sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.